Vexler Vladimir
SEC CIK 1759506 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CHRS | Coherus Oncology, Inc. | CSO | 116.4K | — | — | 7 | 2022-01-04 | 2023-03-31 |
Most active insiders at CHRS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ryan Michael Lee | Dir | — | — |
| 2 | McMichael Bryan J | CFO | — | — |
| 3 | O'Donnell-Tormey Jill | Dir | — | — |
| 4 | Newton Charles W. | Dir | — | — |
| 5 | Newcomer Lee Nisley | Dir | — | — |
| 6 | Satvat Ali J. | Dir | — | — |
| 7 | Karachun Rita A | Dir | — | — |
| 8 | Wahlstrom Mats | Dir | — | — |
| 9 | Lanfear Dennis M | Pres, CEO, Dir | — | — |
Vexler Vladimir made no open-market trades at CHRS in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-04 | 2023-03-31 | CHRS | Coherus Oncology, Inc. | Vexler Vladimir | CSO | F - Tax | $6.84 | -16.3K | 116.4K | -12% | -$111.3K | |
| 2023-01-24 | 2023-01-20 | CHRS | Coherus Oncology, Inc. | Vexler Vladimir | CSO | A - Grant | $0.00 | +40.0K | 131.3K | +44% | $0 | |
| M | 2023-01-12 | 2023-01-10+ | CHRS | Coherus Oncology, Inc. | Vexler Vladimir | CSO | F - Tax | $10.05 | -7,204 | 94.9K | -7% | -$72.4K |
| D | 2023-01-06 | 2023-01-04 | CHRS | Coherus Oncology, Inc. | Vexler Vladimir | CSO | F - Tax | $9.87 | -5,437 | 98.5K | -5% | -$53.7K |
| 2022-04-05 | 2022-04-01 | CHRS | Coherus Oncology, Inc. | Vexler Vladimir | CSO | F - Tax | $12.85 | -3,458 | 104.0K | -3% | -$44.4K | |
| M | 2022-01-12 | 2022-01-10+ | CHRS | Coherus Oncology, Inc. | Vexler Vladimir | CSO | F - Tax | $14.33 | -7,733 | 111.0K | -7% | -$110.8K |
| D | 2022-01-06 | 2022-01-04 | CHRS | Coherus Oncology, Inc. | Vexler Vladimir | CSO | A - Grant | $0.00 | +40.0K | 115.2K | +53% | $0 |
Purchase Sale Sale after option exercise All abbreviations